AdelaideAHebertMD

Dermatology • Bellaire, TX

Pediatric Dermatology

Department of Dermatology, The University of Texas Medical School-Houston

Join to view full profile

Dr. Hebert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hebert's full profile

Already have an account?

Office
6500 West Loop S
Ste 200A
Bellaire, TX 77401
Phone+1 713-500-8260

Fax+1 713-524-3432

Education & Training

University of Texas Medical Branch HospitalsResidency, Dermatology, 1981 - 1984
University of Texas Medical Branch HospitalsInternship, Internal Medicine, 1980 - 1981
Tulane University School of MedicineClass of 1980

Certifications & Licensure

TX State Medical License 1981 - 2025
LA State Medical License 1980 - 2016
IL State Medical License 1984 - 1987
American Board of Dermatology Dermatology
American Board of Dermatology Pediatric Dermatology

Awards, Honors, & Recognition

Top Doctors:SE Texas Castle Connolly, 2013
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Fellow (FAAD) American Academy of Dermatology
Join now to see all

Clinical Trials

Cutivate Lotion HPA Axis Pediatric Study Start of enrollment: 2007 Jul 01
Completed
Phase 4
New Topical Treatment for Continued Pain After Shingles Start of enrollment: 2006 Sep 01
Completed
Phase 1
Novel Topical Treatment of Hand Dermatitis (Eczema) Start of enrollment: 2006 Aug 01
Completed
Phase 1
Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection Start of enrollment: 2010 Apr 01
Completed
Phase 4
The Effect of Weight Loss on Psoriasis Area Severity Index in Adult Psoriasis Patients Start of enrollment: 2010 Jun 01
Withdrawn
Not Applicable
Epiduo Pediatric Acne Study Start of enrollment: 2010 Jun 01
Completed
Phase 4
A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients Start of enrollment: 2012 Nov 01
Completed
DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis Start of enrollment: 2014 Jan 01
Completed
Phase 2
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Dec 01
Completed
Phase 3
Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Study Evaluating Efficacy of Topical Squaric Acid Dibutyl Ester in Children and Adolescents With Alopecia Areata Start of enrollment: 2022 Aug 15
Recruiting
Early Phase 1
Roles: Principal Investigator, Contact
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06
Recruiting
Phase 3
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials.
Adelaide A Hebert, Carsten Flohr, H Chih-Ho Hong, Alan D Irvine, Evangeline Pierce
The Journal of Dermatological Treatment. 2024-12-01
Targeting the aryl hydrocarbon receptor as a strategy to expand the therapeutic armamentarium in atopic dermatitis.
Lawrence F Eichenfield, Jonathan I Silverberg, Adelaide A Hebert, Mark Boguniewicz
The Journal of Dermatological Treatment. 2024-12-01
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials.
Eric L Simpson, Lawrence F Eichenfield, Javier Alonso-Llamazares, Zoe D Draelos, Laura K Ferris
JAMA Dermatology. 2024-11-01

Journal Articles

Glycopyrronium Tosylate in Pediatric Primary Axillary Hyperhidrosis: Post Hoc Analysis of Efficacy and Safety Findings by Age from Two Phase Three Randomized Controlle...
Douglass W Forsha, David M Pariser, Adelaide A Hebert, Dee Anna Glaser, William P Werschler, Pediatric Dermatology
The Cutaneous Manifestations of Tuberous Sclerosis Complex
Mary D DarConte, Adelaide A Hebert, American Journal of Medical Genetics Part C: Seminars in Medical Genetics
Efficacy and Safety of Topical Rapamycin in Patients with Facial Angiofibromas Secondary to Tuberous Sclerosis Complex
Adelaide A Hebert, Joshua A Samuels, John M Slopis, JAMA

Lectures

Late-breaking Research: Clinical Trials
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019
Women's & Pediatric Dermatology Seminar 2013
Global Academy for Medical Education (Elsevier), Newport Beach, California - 10/4/2013
Women's & Pediatric Dermatology Seminar 2013
Global Academy for Medical Education (Elsevier), Newport Beach, California - 10/4/2013

Press Mentions

FDA Approves VTAMA® (Tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and OlderDecember 16th, 2024
FDA Approves Tapinarof Cream 1% for Atopic Dermatitis in Adults and ChildrenDecember 16th, 2024
Roivant Reports Positive Topline Results from ADORING 1, the Second Atopic Dermatitis Phase 3 Trial of VTAMA® (Tapinarof) Cream, 1% in Adults and Children as Young as 2 Years OldMay 16th, 2023
Join now to see all

Professional Memberships

American Academy of Dermatology - AAD
Fellow